Lorenzo, Raquel Bratos, Luisa Sánchez Lorenzo, and Antonio González-Martín. 2017. “Will the Carboplatin-Paclitaxel-Bevacizumab Combination Become the Preferred Option As the First Line in Advanced Cervical Cancer? A Small Experience from a Single Oncologic Center:  ”. Cancer Breaking News 5 (1):21-24. https://doi.org/10.19156/cbn.2017.0035.